These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 989253)

  • 1. The pharmacokinetics of cyclophosphamide in man following treatment with methotrexate.
    Mouridsen HT; Jacobsen E; Faber O
    Acta Pharmacol Toxicol (Copenh); 1976 May; 38(5):508-12. PubMed ID: 989253
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetics of cyclophosphamide in man after treatment with allopurinol.
    Witten J; Frederiksen PL; Mouridsen HT
    Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):392-4. PubMed ID: 7376891
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.
    Faber OK; Mouridsen HT; Skovsted L
    Br J Clin Pharmacol; 1975 Jun; 2(3):281-5. PubMed ID: 791322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.
    Mouridsen HT; Faber O; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):98-106. PubMed ID: 4479366
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of cyclophosphamide in man.
    Cohen JL; Jao JY; Jusko WJ
    Br J Pharmacol; 1971 Nov; 43(3):677-80. PubMed ID: 5157730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cyclophosphamide in renal failure.
    Mouridsen HT; Jacobsen E
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):409-14. PubMed ID: 1173530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbital effects on cyclophosphamide pharmacokinetics in man.
    Jao JY; Jusko WJ; Cohen JL
    Cancer Res; 1972 Dec; 32(12):2761-4. PubMed ID: 4678592
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotransformation of cyclophosphamide in man: influence of prednisone.
    Faber OK; Mouridsen HT; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):195-200. PubMed ID: 4479295
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man.
    Bertino JR
    Arthritis Rheum; 1973; 16(1):79-83. PubMed ID: 4540289
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
    de Bruijn EA; Driessen O; Leeflang P; van Strijen E; van den Bosch N; Hermans J
    Cancer Treat Rep; 1987 Dec; 71(12):1267-9. PubMed ID: 3690535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1979 Sep; 8(3):209-17. PubMed ID: 497087
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of the cytostatic drugs used in the CMF-regimen.
    Slee PH; de Bruijn EA; Driessen OM; Hermans J; van Oosterom AT
    Anticancer Res; 1983; 3(4):269-71. PubMed ID: 6688337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of anticancer agents in man.
    Adamson RH
    Ann N Y Acad Sci; 1971 Jul; 179():432-41. PubMed ID: 4936777
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
    Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
    J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cyclophosphamide in Kenyan Africans.
    Juma F; Ogada T
    Br J Clin Pharmacol; 1983 Jul; 16(1):61-3. PubMed ID: 6882623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites].
    Wagner T; Heydrich D; Bartels H; Hohorst HJ
    Arzneimittelforschung; 1980; 30(9):1588-92. PubMed ID: 7193030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative pharmacology of cyclophosphamide and ifosfamide.
    Colvin M
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution and pharmacokinetics of cyclophosphamide in the rat.
    Talha MR; Rogers HJ; Trounce JR
    Br J Cancer; 1980 Jan; 41(1):140-3. PubMed ID: 7362775
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamide.
    Mouridsen HT; Witten J; Frederiksen PL; Hulsbaek I
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):328-30. PubMed ID: 716950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.